Prevalence and Determinants of Occurrence of Dyslipidemia in Subjects with Type 1 Diabetes Mellitus

被引:4
|
作者
Selvaraj, Meghana [1 ]
Prasad, Hemchand Krishna [2 ]
White, Sherline [1 ]
Prasanna, Bala [1 ]
Sangaralingam, Thangavelu [1 ]
机构
[1] Mehta Multispecial Hosp India Pvt Ltd, Dept Pediat, Chennai, Tamil Nadu, India
[2] Mehta Multispecial Hosp India Pvt Ltd, Dept Pediat Endocrinol, Chennai 600031, Tamil Nadu, India
来源
INDIAN JOURNAL OF PEDIATRICS | 2023年 / 90卷 / 02期
关键词
Dyslipidemia; Type 1 diabetes mellitus; Obesity; Glycosylated hemoglobin; CARDIOVASCULAR-DISEASE; ADOLESCENTS; CHILDREN; RISK; WEIGHT;
D O I
10.1007/s12098-022-04130-2
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective To describe the prevalence and determinants of occurrence of dyslipidemia in children and adolescents with type 1 diabetes mellitus (T1DM). Methods A cross-sectional study was conducted in the diabetic clinic of a tertiary care referral hospital over two years. Subjects with T1DM aged 2-18 y had assessment of Lipid profile after 12 h of fasting. Glycemic control was assessed by glycosylated hemoglobin (HbA1C). Modifiable and nonmodifiable determining factors were assessed during clinic visit as per standard criteria. Body mass index (BMI) more than 23(rd) adult equivalent and 27(th) adult equivalent were considered as overweight and obesity, respectively. Lipid parameters were considered as abnormal if: Low density lipoprotein (LDL) > 100 mg/dL, high density lipoprotein (HDL) < 40 mg/dL, triglycerides > 100 mg/dL (< 10 y) and > 130 mg/dL (> 10 y). Results A total of 171 subjects (mean age: 11.8 +/- 3.5 y, M:F = 75:96) were recruited during the study period. The mean fasting LDL level, HDL level, and triglyceride level observed in the study sample were 106.6 +/- 26.9 mg/dL (62% abnormal), 52.6 +/- 14.3 mg/dL (9.4% abnormal), and 85.3 +/- 39.4 mg/dL (10.5% abnormal), respectively; 115 (67.3%) of the subjects had at least one abnormality in the serum lipid profile. On multivariate analysis, HbA1C was the most significant factor in determining the occurrence of dyslipidemia (p < 0.05). HbA1C was 9.9 +/- 1.6 in subjects with abnormal LDL versus 9.1 +/- 1.5 in those with normal LDL (p < 0.05). Conclusion Prevalence of dyslipidemia in the study children and adolescents with T1DM was 67.3%. HbA1C remains the most important modifiable determinant of the occurrence of dyslipidemia.
引用
收藏
页码:118 / 123
页数:6
相关论文
共 50 条
  • [1] Prevalence and Determinants of Occurrence of Dyslipidemia in Subjects with Type 1 Diabetes Mellitus
    Meghana Selvaraj
    Hemchand Krishna Prasad
    Sherline White
    Bala Prasanna
    Thangavelu Sangaralingam
    [J]. Indian Journal of Pediatrics, 2023, 90 : 118 - 123
  • [2] Dyslipidemia in diabetes mellitus type 1
    Debbabi, W.
    Khochtali, I.
    Baba, A.
    Marmouche, H.
    Bchir, H.
    Mahjoub, S.
    [J]. DIABETES & METABOLISM, 2011, 37 : A75 - A75
  • [3] Dyslipidemia Prevalence, Atherogenicity and Type 2 Diabetes Mellitus
    Opris, Simona
    Constantin, Gianina-Ioana
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2020, 104
  • [4] Prevalence and Clinical Determinants of Obesity in Type 1 Diabetes Mellitus
    Tsushima, Yumiko
    Kashyap, Sangeeta
    Zhou, Keren
    [J]. DIABETES, 2020, 69
  • [5] Prevalence of dyslipidemia in Indian children with poorly controlled type 1 diabetes mellitus
    Shah, Nikhil
    Khadilkar, Anuradha
    Gondhalekar, Ketan
    Khadilkar, Vaman
    [J]. PEDIATRIC DIABETES, 2020, 21 (06) : 987 - 994
  • [6] Prevalence and determinants of osteoporosis in patients with type 1 and type 2 diabetes mellitus
    Leidig-Bruckner, Gudrun
    Grobholz, Sonja
    Bruckner, Thomas
    Scheidt-Nave, Christa
    Nawroth, Peter
    Schneider, Jochen G.
    [J]. BMC ENDOCRINE DISORDERS, 2014, 14
  • [7] Prevalence and determinants of osteoporosis in patients with type 1 and type 2 diabetes mellitus
    Gudrun Leidig-Bruckner
    Sonja Grobholz
    Thomas Bruckner
    Christa Scheidt-Nave
    Peter Nawroth
    Jochen G Schneider
    [J]. BMC Endocrine Disorders, 14
  • [8] Prevalence and Determinants of Painful and Painless Neuropathy in Type 1 Diabetes Mellitus
    Barbosa, Margarida
    Saavedra, Ana
    Oliveira, Sofia
    Reis, Ligia
    Rodrigues, Filipa
    Severo, Milton
    Sittl, Reinhard
    Maier, Christoph
    Carvalho, Davide M.
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [9] Prevalence and phenotypic distribution of dyslipidemia in type 1 diabetes mellitus -: Effect of glycemic control
    Pérez, A
    Wägner, AM
    Carreras, G
    Giménez, G
    Sánchez-Quesada, JL
    Rigla, M
    Gómez-Gerique, JA
    Pou, JM
    de Leiva, A
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (18) : 2756 - 2762
  • [10] Dyslipidemia in young patients with type 1 diabetes mellitus
    Homma, Thais Kataoka
    Endo, Camila Matsuura
    Saruhashi, Tatiana
    Ivata Mori, Ana Paula
    de Noronha, Renata Maria
    Monte, Osmar
    Procopio Calliari, Luis Eduardo
    [J]. ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2015, 59 (03): : 215 - 219